Enhanced immunity against SARS-CoV-2 in returning Chinese individuals-Reference-Cited by-同舟云学术

Enhanced immunity against SARS-CoV-2 in returning Chinese individuals

Published:2024-01-08 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yuan Runyu¹,Chen Huimin¹²,Yi Lina¹,Li Xinxin¹²,Hu Ximing¹³,Li Xing¹,Zhang Huan¹,Zhou Pingping¹,Liang Chumin¹,Lin Huifang¹,Zeng Lilian¹,Zhuang Xue¹,Ruan QianQian¹⁴,Chen Yueling¹⁵,Deng Yingyin¹³,Liu Zhe¹,Lu Jing¹,Xiao Jianpeng¹,Chen Liang¹,Xiao Xincai⁶,Li Jing⁷,Li Baisheng¹,Li Yan¹,He Jianfeng¹,Sun Jiufeng¹²³⁴⁵^ORCID

Affiliation:

1. Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China

2. Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China

3. School of Public Health, Southern Medical University, Guangzhou, China

4. School of Public Health, Sun Yat-Sen University, Guangzhou, China

5. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China

6. Guangzhou Chest Hospital, Guangzhou Medical University, Guangzhou, China

7. Quality Control Department, Sinovac Life Sciences Co. Ltd., Beijing, China

Funder

the Guangdong Science and Technology Program

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy